HIV Virus

**Retroviruses**, such as **HIV**, have an RNA genome that must be reverse transcribed into DNA, which then is incorporated into the host cell genome. They are within group VI of the Baltimore classification scheme. To convert RNA into DNA, retroviruses must contain genes that encode the virus-specific enzyme reverse transcriptase that transcribes an RNA template to DNA. Reverse transcription never occurs in uninfected host cells-the needed enzyme reverse transcriptase is only derived from the expression of viral genes within the infected host cells. The fact that HIV produces some of its own enzymes not found in the host has allowed researchers to develop drugs that inhibit these enzymes. These drugs, including the reverse transcriptase inhibitor AZT, inhibit HIV replication by reducing the activity of the enzyme without affecting the host’s metabolism. This approach has led to the development of a variety of drugs used to treat HIV and has been effective at reducing the number of infectious virions (copies of viral RNA) in the blood to non-detectable levels in many HIV-infected individuals.



*LICENSES AND ATTRIBUTIONS

CC licensed content, Shared previously, Virus Infections and Hosts, Authored by: OpenStax College. License: CC BY: Attribution. License Terms: Download for free at http://cnx.org/contents/GFy_h8cu@9.85:fL0VrVv_@3/Virus-Infections-and-Hosts*